NEWS

Awards, Appointments, Announcements

{blacksquare} At its annual meeting in New Orleans, the American Society of Clinical Oncology (ASCO) announced the recipients of its 2004 special awards:

Larry Norton, M.D., received the David A. Karnofsky Memorial Award, ASCO's highest scientific award, which honors innovative research and developments that have changed the way oncologists think about the practice of oncology. Norton, deputy physician in chief of breast cancer programs at the Memorial Sloan-Kettering Cancer Center in New York, pioneered the so-called dose density approach to therapy, which reduces toxicity and mortality while maximizing the rate of cancer cell death.

Lawrence H. Einhorn, M.D., senior cancer research investigator at Indiana University in Bloomington, received the Distinguished Service Award for Scientific Achievement for his contributions to oncology, including the development of a curative treatment for testicular cancer.

Robert C. Young, M.D., president of the Fox Chase Cancer Center in Philadelphia, was presented with the Distinguished Service Award for Scientific Leadership, in recognition of his nearly 40 years of service in the field of oncology and his contributions to advancing the understanding of ovarian cancer.

Bernard Levin, M.D., vice president for cancer prevention at the University of Texas M. D. Anderson Cancer Center in Houston, received the American Cancer Society Award, which recognizes an individual's significant contributions to the prevention and control of cancer. Levin has contributed to the identification of biochemical and genetic predeterminants for gastrointestinal cancers and has been instrumental in the development of new treatments for these cancers.

A. Thomas Look, M.D., of the Dana-Farber Cancer Institute in Boston, was awarded the Pediatric Oncology Lectureship. Look's research has focused on the transcriptional control of programmed cell death in human acute leukemia and genetic abnormalities of childhood leukemia and solid tumors.

Margaret Foti, Ph.D., chief executive officer of the American Association for Cancer Research (AACR), received the Special Recognition Award for her role in the development of the ASCO/AACR Joint Workshop, "Methods in Clinical Cancer Research." The workshop has been the prototype for subsequent workshops designed to introduce beginning oncologists in Europe and Australia to the essentials of effective clinical trial design.

Paula Kim, co-founder and president of the Pancreatic Cancer Action Network, was presented with the Partners in Progress Award for her commitment to improving the quality of care for pancreatic cancer patients.



             
Copyright © 2004 Oxford University Press (unless otherwise stated)
Oxford University Press Privacy Policy and Legal Statement